NP47924 Cytokine Modulators

{
  "id": "010054-2025",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "36",
        "value": 3,
        "measure": "bids",
        "relatedLot": "1"
      },
      {
        "id": "41",
        "value": 4,
        "measure": "bids",
        "relatedLot": "2"
      },
      {
        "id": "46",
        "value": 1,
        "measure": "bids",
        "relatedLot": "5"
      },
      {
        "id": "51",
        "value": 1,
        "measure": "bids",
        "relatedLot": "3"
      },
      {
        "id": "56",
        "value": 1,
        "measure": "bids",
        "relatedLot": "4"
      },
      {
        "id": "61",
        "value": 1,
        "measure": "bids",
        "relatedLot": "6"
      },
      {
        "id": "66",
        "value": 1,
        "measure": "bids",
        "relatedLot": "7"
      },
      {
        "id": "37",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "1"
      },
      {
        "id": "42",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "2"
      },
      {
        "id": "47",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "5"
      },
      {
        "id": "52",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "3"
      },
      {
        "id": "57",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "4"
      },
      {
        "id": "62",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "6"
      },
      {
        "id": "67",
        "value": 0,
        "measure": "smeBids",
        "relatedLot": "7"
      },
      {
        "id": "38",
        "value": 0,
        "measure": "foreignBidsFromEU",
        "relatedLot": "1"
      },
      {
        "id": "43",
        "value": 0,
        "measure": "foreignBidsFromEU",
        "relatedLot": "2"
      },
      {
        "id": "48",
        "value": 0,
        "measure": "foreignBidsFromEU",
        "relatedLot": "5"
      },
      {
        "id": "53",
        "value": 0,
        "measure": "foreignBidsFromEU",
        "relatedLot": "3"
      },
      {
        "id": "58",
        "value": 0,
        "measure": "foreignBidsFromEU",
        "relatedLot": "4"
      },
      {
        "id": "63",
        "value": 0,
        "measure": "foreignBidsFromEU",
        "relatedLot": "6"
      },
      {
        "id": "68",
        "value": 0,
        "measure": "foreignBidsFromEU",
        "relatedLot": "7"
      },
      {
        "id": "39",
        "value": 0,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "1"
      },
      {
        "id": "44",
        "value": 0,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "2"
      },
      {
        "id": "49",
        "value": 0,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "5"
      },
      {
        "id": "54",
        "value": 0,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "3"
      },
      {
        "id": "59",
        "value": 0,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "4"
      },
      {
        "id": "64",
        "value": 0,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "6"
      },
      {
        "id": "69",
        "value": 0,
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "7"
      },
      {
        "id": "40",
        "value": 3,
        "measure": "electronicBids",
        "relatedLot": "1"
      },
      {
        "id": "45",
        "value": 4,
        "measure": "electronicBids",
        "relatedLot": "2"
      },
      {
        "id": "50",
        "value": 1,
        "measure": "electronicBids",
        "relatedLot": "5"
      },
      {
        "id": "55",
        "value": 1,
        "measure": "electronicBids",
        "relatedLot": "3"
      },
      {
        "id": "60",
        "value": 1,
        "measure": "electronicBids",
        "relatedLot": "4"
      },
      {
        "id": "65",
        "value": 1,
        "measure": "electronicBids",
        "relatedLot": "6"
      },
      {
        "id": "70",
        "value": 1,
        "measure": "electronicBids",
        "relatedLot": "7"
      }
    ]
  },
  "date": "2025-03-19T09:15:55Z",
  "ocid": "ocds-h6vhtk-04b34f",
  "buyer": {
    "id": "GB-FTS-115937",
    "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
  },
  "links": [
    {
      "rel": "canonical",
      "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000781799"
    }
  ],
  "awards": [
    {
      "id": "010054-2025-1",
      "title": "Etanercept",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-141106",
          "name": "Biogen Idec Ltd"
        },
        {
          "id": "GB-FTS-95765",
          "name": "Sandoz"
        },
        {
          "id": "GB-FTS-57454",
          "name": "Pfizer Ltd"
        }
      ],
      "relatedLots": [
        "1"
      ]
    },
    {
      "id": "010054-2025-2",
      "title": "Infliximab IV",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-5312",
          "name": "Celltrion Healthcare United Kingdom Limited"
        },
        {
          "id": "GB-FTS-107241",
          "name": "Janssen Cilag Limited"
        },
        {
          "id": "GB-FTS-141106",
          "name": "Biogen Idec Ltd"
        },
        {
          "id": "GB-FTS-4558",
          "name": "Sandoz Ltd"
        }
      ],
      "relatedLots": [
        "2"
      ]
    },
    {
      "id": "010054-2025-3",
      "title": "Methotrexate pens (25mg/1ml concentration)",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-4550",
          "name": "Accord Healthcare Ltd"
        },
        {
          "id": "GB-FTS-4551",
          "name": "medac Pharma LLP"
        }
      ],
      "relatedLots": [
        "5"
      ]
    },
    {
      "id": "010054-2025-4",
      "title": "Infliximab SC",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-5312",
          "name": "Celltrion Healthcare United Kingdom Limited"
        }
      ],
      "relatedLots": [
        "3"
      ]
    },
    {
      "id": "010054-2025-5",
      "title": "Methotrexate syringes (25mg/1 ml concentration)",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-4550",
          "name": "Accord Healthcare Ltd"
        }
      ],
      "relatedLots": [
        "4"
      ]
    },
    {
      "id": "010054-2025-6",
      "title": "Methotrexate pens (50mg/1 ml concentration)",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-141107",
          "name": "Nordic Pharma Ltd"
        }
      ],
      "relatedLots": [
        "6"
      ]
    },
    {
      "id": "010054-2025-7",
      "title": "Methotrexate syringes (50mg/1ml concentration)",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-141107",
          "name": "Nordic Pharma Ltd"
        }
      ],
      "relatedLots": [
        "7"
      ]
    }
  ],
  "tender": {
    "id": "ocds-h6vhtk-04b34f",
    "lots": [
      {
        "id": "1",
        "title": "Etanercept",
        "status": "cancelled",
        "hasOptions": false,
        "description": "Supply of Etanercept to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        }
      },
      {
        "id": "2",
        "title": "Infliximab IV",
        "status": "cancelled",
        "hasOptions": false,
        "description": "Supply of Infliximab IV to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        }
      },
      {
        "id": "3",
        "title": "Infliximab SC",
        "status": "cancelled",
        "hasOptions": false,
        "description": "Supply of Infliximab SC to NHS Scotland.\nThe Authority intends to award this Lot as a single supplier framework per product line.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        }
      },
      {
        "id": "4",
        "title": "Methotrexate syringes (25mg/1 ml concentration)",
        "status": "cancelled",
        "hasOptions": false,
        "description": "Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3)  Framework Participants.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        }
      },
      {
        "id": "5",
        "title": "Methotrexate pens (25mg/1ml concentration)",
        "status": "cancelled",
        "hasOptions": false,
        "description": "Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3)  Framework Participants.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        }
      },
      {
        "id": "6",
        "title": "Methotrexate pens (50mg/1 ml concentration)",
        "status": "cancelled",
        "hasOptions": false,
        "description": "Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        }
      },
      {
        "id": "7",
        "title": "Methotrexate syringes (50mg/1ml concentration)",
        "status": "cancelled",
        "hasOptions": false,
        "description": "Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "3",
        "relatedLot": "3",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "4",
        "relatedLot": "4",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "5",
        "relatedLot": "5",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "6",
        "relatedLot": "6",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "7",
        "relatedLot": "7",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "NP47924 Cytokine Modulators",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "techniques": {
      "hasFrameworkAgreement": true
    },
    "description": "Supply of Cytokine Modulators to NHS Scotland.",
    "reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
    "classification": {
      "id": "33600000",
      "scheme": "CPV",
      "description": "Pharmaceutical products"
    },
    "procurementMethod": "open",
    "mainProcurementCategory": "goods",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-115937",
      "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ],
      "address": {
        "region": "UKM",
        "locality": "Edinburgh",
        "postalCode": "EH12 9EB",
        "countryName": "United Kingdom",
        "streetAddress": "1 South Gyle Crescent"
      },
      "details": {
        "url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
        "buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
      },
      "contactPoint": {
        "name": "Stephanie McNiven",
        "email": "stephanie.mcniven2@nhs.scot",
        "telephone": "+44 1312756000"
      }
    },
    {
      "id": "GB-FTS-141106",
      "name": "Biogen Idec Ltd",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Maidenhead",
        "postalCode": "SL6 3UD",
        "countryName": "United Kingdom",
        "streetAddress": "Biogen Building 5 Foundation Park, ,  Roxborough Way, Maidenhead, Berkshire, England,"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Biogen Idec Ltd"
      }
    },
    {
      "id": "GB-FTS-5312",
      "name": "Celltrion Healthcare United Kingdom Limited",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Slough",
        "postalCode": "SL1 1QP",
        "countryName": "United Kingdom",
        "streetAddress": "1-7 The Switch"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Celltrion Healthcare United Kingdom Limited"
      }
    },
    {
      "id": "GB-FTS-4550",
      "name": "Accord Healthcare Ltd",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "North Harrow",
        "postalCode": "HA1 4HF",
        "countryName": "United Kingdom",
        "streetAddress": "Sage House, 319 Piner Road"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Accord Healthcare Ltd"
      }
    },
    {
      "id": "GB-FTS-141107",
      "name": "Nordic Pharma Ltd",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Reading",
        "postalCode": "RG7 4SA",
        "countryName": "United Kingdom",
        "streetAddress": "Abbey House, 1650 Arlington Business Park, Theale"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Nordic Pharma Ltd"
      }
    },
    {
      "id": "GB-FTS-95765",
      "name": "Sandoz",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Camberley, Surrey",
        "postalCode": "GU15 3YL",
        "countryName": "United Kingdom",
        "streetAddress": "Park View,  Riverside Way, Watchmoor Park"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Sandoz"
      }
    },
    {
      "id": "GB-FTS-57454",
      "name": "Pfizer Ltd",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Tadworth",
        "postalCode": "KT20 7NS",
        "countryName": "United Kingdom",
        "streetAddress": "Walton Oaks, Dorking Road"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Pfizer Ltd"
      }
    },
    {
      "id": "GB-FTS-107241",
      "name": "Janssen Cilag Limited",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "High Wycombe",
        "postalCode": "HP12 4EG",
        "countryName": "United Kingdom",
        "streetAddress": "50-100, Holmers Farm Way"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Janssen Cilag Limited"
      }
    },
    {
      "id": "GB-FTS-4558",
      "name": "Sandoz Ltd",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Camberley",
        "postalCode": "GU16 7SR",
        "countryName": "United Kingdom",
        "streetAddress": "Frimley Business Park, Frimley"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Sandoz Ltd"
      }
    },
    {
      "id": "GB-FTS-4551",
      "name": "medac Pharma LLP",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Stirling",
        "postalCode": "FK9 4NF",
        "countryName": "United Kingdom",
        "streetAddress": "Scion House, Innovation Park"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "medac Pharma LLP"
      }
    },
    {
      "id": "GB-FTS-324",
      "name": "Sheriff Court House",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Edinburgh",
        "postalCode": "EH1 1LB",
        "countryName": "United Kingdom",
        "streetAddress": "27 Chambers Street"
      },
      "details": {
        "url": "https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts"
      },
      "identifier": {
        "legalName": "Sheriff Court House"
      },
      "contactPoint": {
        "email": "edinburgh@scotcourts.gov.uk",
        "telephone": "+44 1312252525"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "010054-2025-1",
      "title": "Etanercept",
      "value": {
        "amount": 1700000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "010054-2025-1",
      "dateSigned": "2025-01-29T00:00:00Z"
    },
    {
      "id": "010054-2025-2",
      "title": "Infliximab IV",
      "value": {
        "amount": 44300000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "010054-2025-2",
      "dateSigned": "2025-01-29T00:00:00Z"
    },
    {
      "id": "010054-2025-3",
      "title": "Methotrexate pens (25mg/1ml concentration)",
      "value": {
        "amount": 5150000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "010054-2025-3",
      "dateSigned": "2025-01-29T00:00:00Z"
    },
    {
      "id": "010054-2025-4",
      "title": "Infliximab SC",
      "value": {
        "amount": 4200000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "010054-2025-4",
      "dateSigned": "2025-01-29T00:00:00Z"
    },
    {
      "id": "010054-2025-5",
      "title": "Methotrexate syringes (25mg/1 ml concentration)",
      "value": {
        "amount": 577000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "010054-2025-5",
      "dateSigned": "2025-01-29T00:00:00Z"
    },
    {
      "id": "010054-2025-6",
      "title": "Methotrexate pens (50mg/1 ml concentration)",
      "value": {
        "amount": 1000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "010054-2025-6",
      "dateSigned": "2025-01-29T00:00:00Z"
    },
    {
      "id": "010054-2025-7",
      "title": "Methotrexate syringes (50mg/1ml concentration)",
      "value": {
        "amount": 15000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "010054-2025-7",
      "dateSigned": "2025-01-29T00:00:00Z"
    }
  ],
  "description": "The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement.\n(SC Ref:793130)",
  "initiationType": "tender"
}

{
  "id": "035484-2024",
  "tag": [
    "tender"
  ],
  "date": "2024-11-01T13:49:54Z",
  "ocid": "ocds-h6vhtk-04b34f",
  "buyer": {
    "id": "GB-FTS-115937",
    "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
  },
  "links": [
    {
      "rel": "canonical",
      "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000781799"
    }
  ],
  "tender": {
    "id": "ocds-h6vhtk-04b34f",
    "lots": [
      {
        "id": "1",
        "title": "Etanercept",
        "value": {
          "amount": 11337834,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of Etanercept to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.\nFull details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "2",
        "title": "Infliximab IV",
        "value": {
          "amount": 5584117,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of Infliximab IV to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.\nFull details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "3",
        "title": "Infliximab SC",
        "value": {
          "amount": 1364625,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of Infliximab SC to NHS Scotland.\nThe Authority intends to award this Lot as a single supplier framework per product line.\nFull details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "4",
        "title": "Methotrexate syringes (25mg/1 ml concentration)",
        "value": {
          "amount": 57674,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3)  Framework Participants.\nFull details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "5",
        "title": "Methotrexate pens (25mg/1ml concentration)",
        "value": {
          "amount": 57473,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3)  Framework Participants.\nFull details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "6",
        "title": "Methotrexate pens (50mg/1 ml concentration)",
        "value": {
          "amount": 4459687,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.\nFull details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "7",
        "title": "Methotrexate syringes (50mg/1ml concentration)",
        "value": {
          "amount": 101754,
          "currency": "GBP"
        },
        "status": "active",
        "renewal": {
          "description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
        },
        "hasOptions": false,
        "hasRenewal": true,
        "description": "Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland.\nThe Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.\nFull details of Goods and volumes can be found within the ITT documents.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "API Sources",
              "type": "quality",
              "description": "5"
            },
            {
              "type": "price",
              "description": "95"
            }
          ]
        },
        "contractPeriod": {
          "durationInDays": 720
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "3",
        "relatedLot": "3",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "4",
        "relatedLot": "4",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "5",
        "relatedLot": "5",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "6",
        "relatedLot": "6",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      },
      {
        "id": "7",
        "relatedLot": "7",
        "deliveryLocation": {
          "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
        },
        "deliveryAddresses": [
          {
            "region": "UKM"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "NP47924 Cytokine Modulators",
    "status": "active",
    "coveredBy": [
      "GPA"
    ],
    "bidOpening": {
      "date": "2024-12-02T12:00:00Z"
    },
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lotDetails": {
      "maximumLotsBidPerSupplier": null
    },
    "techniques": {
      "frameworkAgreement": {
        "maximumParticipants": 8
      },
      "hasFrameworkAgreement": true
    },
    "awardPeriod": {
      "startDate": "2024-12-02T12:00:00Z"
    },
    "description": "Supply of Cytokine Modulators to NHS Scotland.",
    "tenderPeriod": {
      "endDate": "2024-12-02T12:00:00Z"
    },
    "contractTerms": {
      "hasElectronicPayment": true,
      "hasElectronicOrdering": true,
      "electronicInvoicingPolicy": "allowed"
    },
    "hasRecurrence": false,
    "reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
    "classification": {
      "id": "33600000",
      "scheme": "CPV",
      "description": "Pharmaceutical products"
    },
    "submissionTerms": {
      "languages": [
        "en"
      ]
    },
    "submissionMethod": [
      "electronicSubmission"
    ],
    "procurementMethod": "open",
    "selectionCriteria": {
      "criteria": [
        {
          "type": "technical",
          "minimum": "(a)\tConfirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.\n(b)\tConfirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.\n(c)\tConfirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products.\n(d)\tA completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder’s carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.",
          "appliesTo": [
            "supplier"
          ],
          "description": "(a)\tPotential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.\n(b)\tPotential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.\n(c)\tAll tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.\n(d)\tPotential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond."
        }
      ]
    },
    "mainProcurementCategory": "goods",
    "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-115937",
      "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ],
      "address": {
        "region": "UKM",
        "locality": "Edinburgh",
        "postalCode": "EH12 9EB",
        "countryName": "United Kingdom",
        "streetAddress": "1 South Gyle Crescent"
      },
      "details": {
        "url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
        "buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
      },
      "contactPoint": {
        "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
        "name": "Stephanie McNiven",
        "email": "stephanie.mcniven2@nhs.scot",
        "telephone": "+44 1312756000"
      }
    },
    {
      "id": "GB-FTS-324",
      "name": "Sheriff Court House",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Edinburgh",
        "postalCode": "EH1 1LB",
        "countryName": "United Kingdom",
        "streetAddress": "27 Chambers Street"
      },
      "details": {
        "url": "https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts"
      },
      "identifier": {
        "legalName": "Sheriff Court House"
      },
      "contactPoint": {
        "email": "edinburgh@scotcourts.gov.uk",
        "telephone": "+44 1312252525"
      }
    }
  ],
  "language": "en",
  "description": "The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement.\nThe buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 27889. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343\nA sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363\nCommunity benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/\nA summary of the expected community benefits has been provided as follows:\nIt is a mandatory requirement that potential framework participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework.\nPotential framework participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved.\nPotential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this framework if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits.\nFor further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/).\n(SC Ref:781799)",
  "initiationType": "tender"
}